ED treatment pills: company visibility research
Read company-level analysis of mentions, recommendations, competitor comparisons, and cited sources within a defined research sample.
This is public research, not a client engagement and not an endorsement of any company named. Dates, samples, and limitations are documented in each report.
SHOWING 1-18 OF 19

BlueChew AI Visibility Market Strategy Report - ED Treatment Pills
BlueChew is visible in AI answers for ED treatment pills but converts that presence into recommendations less often than leading competitors.
- Type
- AI Visibility Company Market Strategy Report
- Source
- LLM Authority Index benchmark data
- Status
- Independent market analysis

Lemonaid Health AI Visibility Market Strategy Report - ED Treatment Pills
Lemonaid Health ranks fourth in ED treatment pills with strong positive sentiment but limited first-choice placement in AI recommendations.
- Type
- AI Visibility Company Market Strategy Report
- Source
- LLM Authority Index benchmark data
- Status
- Independent market analysis

GoodRx Care AI Visibility Market Strategy Report - ED Treatment Pills
GoodRx Care gained ground in ED treatment pills, with stronger first-position recommendations, higher presence, and positive sentiment across AI Overviews and.
- Type
- AI Visibility Company Market Strategy Report
- Source
- LLM Authority Index benchmark data
- Status
- Independent market analysis

K Health AI Visibility Market Strategy Report - ED Treatment Pills
K Health appears in AI answers for ED treatment pills but is rarely recommended. This benchmark shows low mention volume, no rank-one placements, and stronger.
- Type
- AI Visibility Company Market Strategy Report
- Source
- LLM Authority Index benchmark data
- Status
- Independent market analysis

Blink Health AI Visibility Market Strategy Report - ED Treatment Pills
Blink Health appears in AI responses for ED treatment pills but converts that presence into recommendations less often than category leaders.
- Type
- AI Visibility Company Market Strategy Report
- Source
- LLM Authority Index benchmark data
- Status
- Independent market analysis

Hims AI Visibility Market Strategy Report - ED Treatment Pills
Hims leads the ED treatment pills category in valid recommendations, top-three placements, and rank-one share across major AI platforms.
- Type
- AI Visibility Company Market Strategy Report
- Source
- LLM Authority Index benchmark data
- Status
- Independent market analysis

Ro AI Visibility Market Strategy Report - ED Treatment Pills
Ro ranks second in the ED treatment pills benchmark, with strong shortlist inclusion across AI Overviews and AI Mode but a much lower first-place.
- Type
- AI Visibility Company Market Strategy Report
- Source
- LLM Authority Index benchmark data
- Status
- Independent market analysis

plushcare AI Visibility Market Strategy Report - ED Treatment Pills
plushcare enters the ED treatment pills benchmark with solid mention presence and positive sentiment, but weak top-three and rank-one placement.
- Type
- AI Visibility Company Market Strategy Report
- Source
- LLM Authority Index benchmark data
- Status
- Independent market analysis

Optum AI Visibility Market Strategy Report - ED Treatment Pills
Optum appears in a small share of ED treatment pill prompts but is rarely recommended, with most mentions staying neutral and no first-place placements.
- Type
- AI Visibility Company Market Strategy Report
- Source
- LLM Authority Index benchmark data
- Status
- Independent market analysis

Rex MD AI Visibility Market Strategy Report - ED Treatment Pills
Rex MD’s October 2026 benchmark shows 8.8% valid recommendation coverage in ED treatment pills, with stronger rank-one placements than several rivals but a.
- Type
- AI Visibility Company Market Strategy Report
- Source
- LLM Authority Index benchmark data
- Status
- Independent market analysis

ZipHealth AI Visibility Market Strategy Report - ED Treatment Pills
ZipHealth was absent from 21 high-intent pricing and affordability prompts in a May 2026 benchmark, while Ro, Sesame, and BlueChew appeared in comparison.
- Type
- AI Visibility Company Market Strategy Report
- Source
- LLM Authority Index benchmark data
- Status
- Independent market analysis

Sesame AI Visibility Market Strategy Report - ED Treatment Pills
Sesame appears often in pricing and affordability prompts for telehealth and ED treatment pills, but only as a neutral reference.
- Type
- AI Visibility Company Market Strategy Report
- Source
- LLM Authority Index benchmark data
- Status
- Independent market analysis

Rugiet Men AI Visibility Market Strategy Report - ED Treatment Pills
Rugiet Men was absent from 21 high-intent pricing and affordability prompts in a May 2026 benchmark, while Ro, Sesame, and BlueChew appeared in comparison.
- Type
- AI Visibility Company Market Strategy Report
- Source
- LLM Authority Index benchmark data
- Status
- Independent market analysis

Optum Perks AI Visibility Market Strategy Report - ED Treatment Pills
Optum Perks was absent from 21 ED treatment pricing prompts in a May 2026 benchmark, while Ro, Sesame, and BlueChew appeared in affordability comparisons.
- Type
- AI Visibility Company Market Strategy Report
- Source
- LLM Authority Index benchmark data
- Status
- Independent market analysis

Noom AI Visibility Market Strategy Report - ED Treatment Pills
Noom appears in the broader competitor metadata, but this May 2026 benchmark does not include it in the measured company universe.
- Type
- AI Visibility Company Market Strategy Report
- Source
- LLM Authority Index benchmark data
- Status
- Independent market analysis

Maximus Tribe AI Visibility Market Strategy Report - ED Treatment Pills
Maximus Tribe was absent from 21 Gemini-led pricing and affordability prompts in the May 2026 ED treatment benchmark, while Ro, Sesame, and BlueChew appeared.
- Type
- AI Visibility Company Market Strategy Report
- Source
- LLM Authority Index benchmark data
- Status
- Independent market analysis

LifeMD AI Visibility Market Strategy Report - ED Treatment Pills
LifeMD is absent from a May 2026 ED treatment pills pricing benchmark, with no measured mentions or recommendations across 21 prompts.
- Type
- AI Visibility Company Market Strategy Report
- Source
- LLM Authority Index benchmark data
- Status
- Independent market analysis

Herbalife AI Visibility Market Strategy Report - ED Treatment Pills
Herbalife appears in the competitor metadata, but the measured ED treatment benchmark does not include it in the company universe.
- Type
- AI Visibility Company Market Strategy Report
- Source
- LLM Authority Index benchmark data
- Status
- Independent market analysis
How to read these reports
Check the date and sample
Read the observation dates, questions, and platforms before comparing one report with another.
Separate a mention from a qualified recommendation
Being named in an answer is not the same as being recommended for a specific buying question.
Know what a public sample can answer
Public research frames the questions; a company-specific brief is agreed with you before any work starts.
Give your next visibility decision a clearer starting point.
We agree the questions, the platforms, the output, and the price before any work starts. We review every request manually and respond within one business day.

